UNSPSC 51413003: Eritrityl tetranitrate

This classification denotes a vasodilating agent with the molecular formula C4H6N4O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 35X333P19D, chemically known as 1,2,3,4-butanetetrol, tetranitrate, (r*,s*)- but generally known as eritrityl tetranitrate, which bears US NIH Compound Identifier 23723. European Medicines Agency schedules Eritrityl tetranitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06600MIG.

UNSPSC 51413003 Eritrityl tetranitrate is a Commodity code that captures pharmaceutical products procured by state and local public health and emergency services agencies for clinical and emergency medical applications. The code encompasses specific pharmaceutical formulations, including vasodilators and cardiac medications, supplied to fire rescue departments, health and human services commissions, and cooperative purchasing alliances serving multiple state and local jurisdictions. State and local buying under this code centers on Advanced Life Support medications and generic multi-source pharmaceuticals distributed through authorized wholesalers to public health facilities, with vendors required to meet FDA compliance, cGMP certification, Drug Supply Chain Security Act (DSCSA) standards, and expiration-dating requirements (typically nine months to one year minimum shelf life from acceptance or manufacture).

Recent activity spans Florida, Texas, and Minnesota, with the City of Tampa's Purchasing Department issuing an Invitation for Bid (IFB) No. 26P00188 on April 24, 2026, for Advanced Life Support Medications to supply Tampa Fire Rescue with 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with sealed bids due April 8, 2026, and an estimated contract value of $40,000.00 under a Small Local Business Enterprise sheltered-market designation. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued a Request for Proposal on January 20, 2026, closing March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC, with contract terms effective July 1, 2026. The Texas Health and Human Services Commission issued Request for Information No. HHS0017013 on March 27, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, with responses due April 3, 2026, as a preliminary market intelligence phase to inform future formal solicitations. Cooperative purchasing vehicles and state-administered multi-jurisdictional alliances are the dominant issuing model in the recent pipeline under this code.